Abstract 1136 Engineering yeast Hsp104 through nucleotide-binding domain 2 to counter human proteotoxicity

The yeast Hsp104 disaggregase is a powerful ATP-dependent machine that dissolves various misfolded protein states in yeast upon stress and returns them to their native, functional conformations. Leveraging Hsp104 against toxic protein aggregation in neurodegenerative diseases may provide much-needed therapeutic benefit. However, such a path is challenging since toxic disease substrates in humans have no yeast homologs and humans have no Hsp104 homolog. We have previously engineered Hsp104 to dissolve human disease substrates to overcome this challenge and enhance Hsp104 disaggregation activity while limiting off-target toxicity.

Authors

Institutions

Publication Details

Journal
Journal of Biological Chemistry
Published
2025-05-01
DOI
https://doi.org/10.1016/j.jbc.2025.109868
Primary Topic
Viral Infectious Diseases and Gene Expression in Insects
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 1136 Engineering yeast Hsp104 through nucleotide-binding domain 2 to counter human proteotoxicity

Zarin Tabassum, JiaBei Lin, Rachel L. Flores, Zoe Chen et al.
Journal of Biological Chemistry
Viral Infectious Diseases and Gene Expression in Insects
article

Abstract 1136 Engineering yeast Hsp104 through nucleotide-binding domain 2 to counter human proteotoxicity

Zarin Tabassum, JiaBei Lin, Rachel L. Flores, Zoe Chen, Daniel R. Southworth, James Shorter, Alondra N. Betancourt
article en

Abstract

The yeast Hsp104 disaggregase is a powerful ATP-dependent machine that dissolves various misfolded protein states in yeast upon stress and returns them to their native, functional conformations. Leveraging Hsp104 against toxic protein aggregation in neurodegenerative diseases may provide much-needed therapeutic benefit. However, such a path is challenging since toxic disease substrates in humans have no yeast homologs and humans have no Hsp104 homolog. We have previously engineered Hsp104 to dissolve human disease substrates to overcome this challenge and enhance Hsp104 disaggregation activity while limiting off-target toxicity.

Journal of Biological ChemistryVol. 301(5)
Pennsylvania State University (US)
National Science Foundation
Zero hunger
Openalex Percentile: Top 88%
Viral Infectious Diseases and Gene Expression in Insects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Abstract 1136 Engineering yeast Hsp104 through nucleotide-binding domain 2 to counter human proteotoxicity — Zarin Tabassum, JiaBei Lin, et al. · Journal of Biological Chemistry (2025) | TGRS Research Map | TGRS